FDA Inspection
North Shore University Hospital Northwell HealthNorth Shore University Hospital Northwell Health – FDA Inspection, Mar 4, 2026
Record Details
This FDA Inspection record concerns North Shore University Hospital Northwell Health, with an inspection on March 4, 2026, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 4, 2026
- Product Type
- Biologics
View Company Profile
ID · 1ad9d199-eb9f-49c0-b826-4a13e7f5c9e8
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1307150
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of North Shore University Hospital Northwell Health
16| Date | Classification | Office | Project area |
|---|---|---|---|
| March 11, 2026 | Not classified | New York District Office | Blood and Blood Products |
| June 12, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 26, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 20, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| March 12, 2020 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for North Shore University Hospital Northwell Health
- FDA Inspection 1306816 - 2026-03-11
- FDA Inspection 1241373 - 2024-06-12
- FDA Inspection 1203742 - 2023-04-26
- FDA Inspection 1174916 - 2022-07-20
- FDA Inspection 1120549 - 2020-03-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.